Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.71M Buy
39,150
+9,999
+34% +$1.15M 0.2% 106
2025
Q4
$3.09M Sell
29,151
-26,600
-48% -$2.5M 0.24% 104
2025
Q3
$5.02M Sell
55,751
-25,973
-32% -$2.14M 0.41% 54
2025
Q2
$6.47M Buy
81,724
+10,222
+14% +$813K 0.57% 37
2025
Q1
$6.42M Buy
71,502
+16,605
+30% +$1.55M 0.58% 45
2024
Q4
$5.46M Sell
54,897
-47,965
-47% -$4.94M 0.48% 51
2024
Q3
$11.5M Buy
102,862
+14,128
+16% +$1.68M 1.2% 21
2024
Q2
$11M Buy
88,734
+67,918
+326% +$8.75M 1.37% 19
2024
Q1
$2.75M Sell
20,816
-5,784
-22% -$713K 1.15% 31
2023
Q4
$2.89M Hold
26,600
1.24% 28
2023
Q3
$2.73M Hold
26,600
1.33% 24
2023
Q2
$3.07M Buy
26,600
+20,000
+303% +$2.27M 1.41% 20
2023
Q1
$702K Sell
6,600
-20,000
-75% -$2.16M 0.3% 76
2022
Q4
$2.95M Buy
26,600
+6,500
+32% +$664K 1.27% 28
2022
Q3
$1.73M Buy
20,100
+13,500
+205% +$1.21M 0.81% 45
2022
Q2
$602K Hold
6,600
0.09% 133
2022
Q1
$551K Buy
+6,600
New +$520K 0.07% 142

Other funds holding MRK

LGT Fund Management's MRK Position: Q1 2026 in Review

LGT Fund Management increased its Merck (MRK) stake by 34% in Q1 2026, buying an estimated $1.15M and bringing the position to 39,150 shares worth $4.71M. The position accounts for 0.2% of the portfolio, ranked #106.

LGT Fund Management first reported a position in MRK in Q1 2022 and has held it in 17 quarters since. The position peaked at $11.5M in Q3 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • LGT Fund Management held 39,150 shares of Merck worth $4.71M as of Q1 2026.
  • LGT Fund Management bought 9,999 Merck shares in Q1 2026, an estimated $1.15M.
  • Merck made up 0.2% of LGT Fund Management's portfolio in Q1 2026, its #106 holding.
  • LGT Fund Management first reported a position in Merck in Q1 2022 and has held it in 17 quarters since.
  • LGT Fund Management's Merck position peaked at $11.5M in Q3 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on LGT Fund Management's 13F filing for Q1 2026, filed 28 Apr 2026.